Lycopene Health Claim For Cancer Risk Reduction Requested In Petition
This article was originally published in The Tan Sheet
Executive Summary
There is significant scientific agreement among experts that lycopene is an "effective modifier of the risk of certain cancers," supplement marketer American Longevity states in a June 4 health claim petition to FDA
You may also be interested in...
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction